Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
    • Hotels
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

Ansys, Synopsys and China

Barron's on MSN · 6h
Synopsys Buy of Ansys Gets China OK. The $35 Billion Deal Is Set to Close.
Synopsys stock was falling Monday after the chip-design software company received conditional regulatory approval from China to move forward with its $35 billion acquisition of Ansys.The two companies were awaiting clearance from China’s State Administration for Market Regulation,
Yahoo Finance · 9h
Synopsys Set to Close $35 Billion Ansys Deal After China’s Nod
Chip-design software maker Synopsys Inc. secured China’s approval to buy Ansys Inc., setting the stage to close the $35 billion deal later this week.Most Read from BloombergWhy Did Cars Get So Hard to See Out Of?
CNBC on MSN · 7h
China conditionally approving Synopsys' acquisition of Ansys
CNBC’s Eunice Yoon joins 'The Exchange' to discuss China conditionally approving Synopsys' acquisition of Ansys.
15h
China approves $35bn Synopsys chip software deal after US eases export curbs
Beijing’s antitrust regulator had paused process in May as Trump administration tightened access to chip design tools ...
2h
Sunnyvale software firm gets green light to acquire company for $35B
China approves of the acquisition after Trump eased restrictions on semiconductor chip exports to China. Visit ...
11d
Synopsys Cleared For China Sales, But Not For This Valuation
Synopsys is set for a faster rebound due to China sales resuming, an $8B backlog, and strong AI-driven tool demand. Click ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy